Gilead Sciences (NASDAQ:GILD) shares surged 4.5% to $172.99 in premarket trading on Friday after the biopharmaceutical ...
On Sept. 1, 2026, however, Drexel University abruptly announced that the museum would close by the end of the month, citing ...
Dr. James Suen, the Emeritus Professor of Otolaryngology at the University of Arkansas for Medical Sciences, was honored ...
The University of New Mexico Health Sciences Center reopened to patients Tuesday, after what hospital officials called a ...
Philadelphia City Council is investigating what went wrong with the beloved Academy of Natural Sciences of Drexel University.
Trade Brains on MSN
RPG Life Sciences Q2: net profit stands at Rs28.2 Cr on 16.5% revenue growth; API subsidiary restructuring and acquisitions shape earnings
India, Oct. 30 -- The integrated pharmaceutical company RPG Life Sciences has closed its September quarter with strong sales ...
Sellas Life Sciences remains a 'Strong Sell,' as the REGAL trial delay signals increased risk of failure and diminished ...
Trade Brains on MSN
Alivus Life Sciences jumps 7% as EBITDA margin hits record 41.8%: What's driving the profit surge?
India, Oct. 30 -- The shares of one of the leading developers and manufacturers of select, high-value, non-commoditized active pharmaceutical ingredients (APIs) in chronic therapeutic areas are in ...
Symbiosis University of Applied Sciences (SUAS), Indore, organised a felicitation ceremony to honour Dr. Swati Mujumdar on ...
RIT biomedical sciences student used her CPR skills to save a neighbor. RIT’s biomedical sciences degree program prepares ...
Gilead Sciences (GILD) has an average rating of overweight and mean price target of $172.60, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from ...
The trio worked together at Womble Bond Dickinson and bring significant intellectual property knowledge to Honigman as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results